Dr Graham Mazereeuw

Biographie

École de médecine

• Université de Toronto, 2019

Résidence

• Médecine familiale, Université de Toronto, 2021
• Médecine d’urgence, Université d’Ottawa, 2022

Intérêts personnels

• Activités en extérieur
• Soccer (Première ligue)
• Blagues de papa

Publications

1. Mazereeuw G, Gomes T, Macdonald EM, Greaves S, Li P, Mamdani MM, Redelmeier DA, Juurlink DN, 2020. Oxycodone, hydromorphone and the risk of suicide: a retrospective population-based case-control study. Drug Safety 43(8): 737-43;
2. Mazereeuw G, Sullivan MD, Juurlink DN, 2018. Depression in chronic pain: might opioids be responsible? PAIN 159(11): 2142-2145;
3. Cressman AM, Mazereeuw G, Guan Q, Xia W, Gomes T, Juurlink DN, 2017. Availability of naloxone in Canadian pharmacies. Canadian Medical Association Journal – Open 5(4): E779-84;
4. Mazereeuw G, Herrmann N, Oh PI, Ma DWL, Wang CT, Kiss A, Lanctôt KL, 2016. Omega-3 fatty acids, depressive symptoms, and cognitive performance in coronary artery disease patients: analyses from a randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology 36(5): 436-44